Skip to main content
    E

    Emergent Biosolutions Inc (EBS)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NYSE

    $5.80
    +0.02 (+0.26%)

    Market Cap: $297.69M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Emergent Biosolutions Inc (EBS) Government Contracts

    Updated Aug 4, 2026. Contract data from federal award records.

    Federal agencies obligated $277.58M to Emergent Biosolutions over the 12 months through Jul 31, 2026, up 13.9% from the prior 12 months. Department of Health and Human Services was the top awarding agency with 92.2% of obligations across 2 agencies. Emergent Biosolutions had obligation activity on 11 federal contracts over the same 12 months, including 3 new contracts.

    Federal Obligations

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated.

    Obligations
    $277.58M
    Change
    +13.9%
    Obligations to revenue
    41.0%
    Prior 12 months$243.79M
    Contracts with activity11
    New contracts3
    Top agencyDepartment of Health and Human Services
    Top agency share92.2%
    Agencies2
    Average remaining term6.6 months

    12 months through Jul 31, 2026

    Largest New Awards

    The 3 largest new awards total $21.55M, and the largest makes up 99.9% of that.

    Award IDAgencyRecipientAmountStartEndDescription
    W911SR26FA005Department of Defense, Department of the ArmyEMERGENT BIODEFENSE OPERATIONS LANSING LLC$21.53MJan 4, 2026Sep 30, 2029FOR THE PROCUREMENT OF BIOTHRAX (ANTHRAX VACCINE ABSORBED (AVA))
    75N98026P00379Department of Health and Human Services, National Institutes of HealthEMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.$11,232Apr 27, 2026Mar 31, 2027HIV BIOLOGICS MASTER FILE SUPPORT POP: 4/27/26 TO 3/31/27, EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG, INC.
    75D30126P20965Department of Health and Human Services, Centers for Disease Control and PreventionEMERGENT BIODEFENSE OPERATIONS LANSING LLC$2,825Apr 10, 2026Apr 15, 2026BIO THRAX VACCINE
    New federal contracts awarded in the 12 months through Jul 31, 2026, largest first.

    Monthly Obligations

    The latest complete month, Apr 2026, had $14,057 in obligations. The largest month in the table was May 2026, at $64.52M.

    MonthObligations
    Jul 2026-$1
    Jun 2026$52.78M
    May 2026$64.52M
    Apr 2026$14,057
    Mar 2026$60.91M
    Feb 2026$0
    Jan 2026$14.36M
    Dec 2025$0
    Nov 2025$0
    Oct 2025$0
    Sep 2025$55M
    Aug 2025$30M
    MonthObligations
    Jul 2025$51.92M
    Jun 2025$62.39M
    May 2025$0
    Apr 2025$0
    Mar 2025$6.93M
    Feb 2025$0
    Jan 2025$23.61M
    Dec 2024$56.68M
    Nov 2024$0
    Oct 2024$0
    Sep 2024$356,790
    Aug 2024$41.91M

    Net obligations recorded each month, newest first. Agencies report contract actions with a delay (the Defense Department about 90 days), so the latest months, May to Jul 2026, are still incomplete and the 12-month total usually rises as agencies report the rest.

    Frequently Asked Questions About EBS

    How much does Emergent Biosolutions receive in federal contracts?

    Emergent Biosolutions had $277.58M in federal contract obligations over the 12 months through Jul 31, 2026, compared with $243.79M in the 12 months before, up 13.9%. Obligations are contract bookings by the awarding agency, not recognized revenue.

    What are Emergent Biosolutions' largest government contracts?

    The largest new awards over the 12 months through Jul 31, 2026 were W911SR26FA005, Department of Defense, $21.53M, started Jan 4, 2026; 75N98026P00379, Department of Health and Human Services, $11,232, started Apr 27, 2026; 75D30126P20965, Department of Health and Human Services, $2,825, started Apr 10, 2026.

    Which agencies award Emergent Biosolutions contracts?

    Department of Health and Human Services was the top awarding agency with 92.2% of obligations over the 12 months through Jul 31, 2026. The records cover 2 agencies. Other agencies in the awards list include Department of Defense.

    What new federal contracts did Emergent Biosolutions win in the 12 months through Jul 31, 2026?

    Emergent Biosolutions won 3 new federal contracts in the 12 months through Jul 31, 2026. The largest was W911SR26FA005, Department of Defense, $21.53M, started Jan 4, 2026.

    How do Emergent Biosolutions' federal obligations compare with its revenue?

    Federal contract obligations were $277.58M over the 12 months through Jul 31, 2026, equivalent to 41.0% of Emergent Biosolutions' revenue. Obligations are amounts the government committed to contracts in the period, not the share of Emergent Biosolutions' revenue that comes from the government.